BDBM590801 (R)-6-(5-(difluoromethoxy)pyridin-2- yl)-N-(1-(4-fluorophenyl)ethyl)-1-(2- morpholinoethyl)-2-oxo-1,2-dihydro- 1,8-naphthyridine-3-carboxamide::US11564928, Compound 48

SMILES C[C@@H](NC(=O)c1cc2cc(cnc2n(CCN2CCOCC2)c1=O)-c1ccc(OC(F)F)cn1)c1ccc(F)cc1

InChI Key InChIKey=MKBDKTCIMDHMTA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590801   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590801(US11564928, Compound 48 | (R)-6-(5-(difluoromethox...)
Affinity DataIC50: 4.5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590801(US11564928, Compound 48 | (R)-6-(5-(difluoromethox...)
Affinity DataIC50: 1.00E+4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent